MSK Direct is a national cancer benefits solution that improves health outcomes and equity.

MSK Direct is a national cancer benefits solution that provides more than 5.5 million employees, union members, and their families with equitable, personalized access to the lifesaving discoveries and subspecialized expertise of Memorial Sloan Kettering Cancer Center (MSK).

The number 137

Employers and unions

The number 5 million

Covered lives

The number 10,000

MSK Direct patients

With services that span screening and prevention, diagnosis, treatment, and life beyond cancer for both adult and pediatric patients, MSK Direct measurably improves health outcomes and drives value through every person’s unique cancer journey.

Black Female Professional Smiles Confidently
For Employers
A forward-thinking investment in your employees’ health.
Where and how your employees are treated first matters. MSK Direct helps you protect the people you depend on most, wherever they live.
Why choose MSK Direct for your employees?
Hispanic male factory worker with confident/serious expression
For Unions
Making world-class cancer care accessible to all.
For those facing or concerned about cancer, MSK Direct services span screening and prevention programs, to in-person and virtual services, to life-changing cancer care.
Explore MSK Direct for your members
Health Benefits Consultants in Discussion Around Table
For Benefits Consultants
Accurate diagnoses. Better outcomes.
MSK Direct is the nation’s largest employer cancer benefits program, enabling access to MSK’s exceptional cancer care to measurably improve outcomes and drive value.
Discover the MSK Direct difference
Young female and male coworkers walking downstairs looking at iPad
For Health Plans
Innovations in cancer care delivery.
MSK Direct improves cancer outcomes and reduces costs, guiding members toward the highest-quality cancer care that consistently delivers optimal value.
Learn more about the value of MSK Direct

MSK Direct has earned an industry-leading NPS of 86.*

*63% of current partners responded to the survey.